Comment on: Efficacy and Safety of the Duodenojejunal Bypass Liner in Patients With Metabolic Syndrome. Not Yet the Time to Abandon the Duodenal-Jejunal Bypass Liner Concept
Ann Surg
.
2021 Dec 1;274(6):e862-e863.
doi: 10.1097/SLA.0000000000004744.
Authors
Amador García Ruiz de Gordejuela
,
Marc Beisani
1
,
Manoel Galvao Neto
2
Affiliations
1
Endocrine, Metabolic and Bariatric Surgery Unit, General Surgery Department, Vall d'Hebron University Hospital, Barcelona, Spain.
2
Scientific Director of Endovitta Institute, Sao Paulo, Brazil.
PMID:
33443892
DOI:
10.1097/SLA.0000000000004744
No abstract available
Publication types
Letter
Comment
MeSH terms
Bariatric Surgery*
Humans
Metabolic Syndrome*
Obesity, Morbid*